Notice of Intent to Award to Sole Source - 1ML Serum
Closed Pre-Solicitation Posted
- Solicitation number
- 85882
- Agency
-
CDC Office of Acquisition Services
Centers for Disease Control and Prevention, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Atlanta, Georgia 30329, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to Creative Testing Solutions for supplies or services. The primary objectives are to understand the association between state of residence and presence of antibodies directed against alpha-gal, and to determine the association between blood type and the presence of these antibodies. To meet these objectives, the CDC requires nationally representative blood donor specimens with known zip code of residence and blood type, which Creative Testing Solutions can provide through its access to specimens from multiple blood collection agencies across the United States. This procurement falls under the North American Industry Classification System code 325414 - Biological Product (except Diagnostic) Manufacturing. Interested parties may identify their interest and capability to respond, and any responses received within seven days will be considered, though this is not a request for competitive proposals.
There is no set-aside designation for this procurement. Creative Testing Solutions is the only identified potential contractor, as the CDC has determined that it can uniquely provide the required nationally representative blood donor specimens with the necessary geographic and blood type information. The government will make a determination on whether to conduct a competitive procurement based on the responses received. The contract value or budget range is not specified in the notice.
Notice text
•The Centers for Disease Control and Prevention (CDC) intends to award a sole source, firm fixed price contract to Creative Testing Solutions.
•This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). The North American Industry Classification System code for this procurement is 325414 - Biological Product (except Diagnostic) Manufacturing. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.
•This notice of intent is not a request for competitive proposals; however, all responses received within seven (7) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to the contract specialist Ruben Reyes at qmz3@cdc.gov by 12:00PM, August 29, 2024.
More Information:
•Serum from blood donations will be used to analyze from 3,000 donations across10 selected US States. Also obtained will be geographic and blood group information from respective blood collection organizations.
•The primary objectives of our project are to understand 1) the association between state of residence and presence of antibodies directed against alpha-gal and 2) to determine the association between blood type and the presence of antibodies directed against alpha-gal. To meet these objectives, we require blood donor specimens that are 1) nationally representative, 2) from blood donors for whom the zip code of residence is known 3) for whom the blood type is known. Serum specimens provided through Clinical Testing Solutions (CTS) comprise a unique combination of blood donor specimens from multiple separate blood collection agencies across the United States. CTS also has access to geographic details and blood type of donors, which is not provided through other sources. CTS’s access to combine blood donor specimens from various entities allows for a national reach that cannot be achieved through a single blood donor agency. To meet the goals of this project, it is critical we have specific geographic areas sampled and know precise locations of place of residency. We could not identify other vendors with similar geographic coverage and national representation. Additionally, specimens provided through CTS allow for identification of residence at the zip code level, which is not available from other sources. Serum specimens provided through CTS also contain information on blood type, and blood type is critical for the proposed serological survey since it has been associated with the development of IgE antibodies directed against alpha-gal. Other sources of specimens are not able to provide information on blood type.
Files
| File | Type | Posted |
|---|---|---|
| Redacted SSJ.pdf |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity